A lifelong autoimmune intestinal disorder, found in individuals who are genetically susceptible. Until today, I had never heard of Celiac disease. It's amazing the things I learn from participating in these dNeero paid surveys.
Genetic tests exist for Celiac disease and are highly accurate for determining the risk of the disease. When a complete genetic panel is performed the possibility that someone having or ever getting Celiac disease can be determined to an extremely high degree of certainty. Unfortunately, some tests are misleading because they do not include a portion of the genetic pattern that may be present that can predispose to the disease yet the report may imply absence of increased risk. Some tests can be done without a doctor’s order. Insurance coverage for the tests is highly variable. A couple of laboratories can run the tests on samples obtained from a mouth swab that is painless and well accepted by children. Genetic testing can be done at any age whereas blood tests for Celiac disease are no
In a previous report on the probiotic VSL#3, I stated that VSL#3 DS (double strength) came in a capsule form that is gluten free. VSL#3 DS does not come in capsules. However, it does appear to be gluten free. VSL#3 DS is only available in sachets of powder. VSL#3 DS requires a prescription but the other forms of VSL#3 are available over the counter (OTC) without the need of a doctor's prescription. As far as I can determine, the prescription strength form of VSL#3, VSL#3 DS, is gluten free since it is unflavored. The flavored form of VSL#3 powder contains maltose that according to the manufacturer, is derived from barley. Though they report the maltose is highly processed to the point they believe no gluten residues remain they cannot insure it is gluten-free. To take VSL#3 DS and VSL#3 O
The mouth may produce the specific diagnostic blood antibodies and manifest the characteristic microscopic changes of celiac disease according to a study published by researchers from Palermo, Italy. Both endomysial antibody (EMA) and tissue transglutaminase antibodies (TTG) were detectable in more than half of twenty eight adults and children with newly diagnosed celiac disease who agreed to participate in the study. The presence of and degree of lymphocyte infiltration in the mouth correlated well with the detection of antibodies from swab of the mouth. Further research into the feasibility of diagnosing celiac disease from sampling of the mouth without requiring a small intestine biopsy is indicated. Combined with genetic testing for presence of HLA DQ2 and/or DQ8, currently obtainable from a mouth swab, such testing could be highly accurate and non-invasive. It must be remembered that using EMA and TTG and presence of either DQ2 and/or DQ8 will select out those with celiac disease
Living with celiac disease and diabetes can be a challenge, but you can manage them.
Celiac disease is linked with gluten protein in oats, wheat, rye and barley.
The nutrient absorbing lining of the small intestine, called villi, is damaged by the gluten.
This damage can result in diarrhea, vitamin deficiencies and weight loss.
The [...]
How Celiac disease and gluten ingestion results in neurological injury is not well understood. It is however now well recognized that celiac disease and gluten are related to a variety of brain and peripheral nerve problems. According to a new study, nerve cell death, known in medicine by the term apoptosis, occurs in celiac disease not just from the presence antibodies against nerve cells in the blood of people with celiac disease with neurologic problems but from other factors in the blood, especially gliadin and tissue transglutaminase antibodies, and in people without obvious neurological problems. The presence of antibodies to gliadin and tissue transglutaminase in the blood are associated with nerve cell death in the absence of anti-nerve antibodies. The complicated nature of the process that gluten ingestion and celiac disease results in neurological damage can be appreciated by the reading the study by Cervio et al. from the University of Bologna, Italy, published in the July 2
Eosinophilic esophagitis may be a manifestation of celiac disease and gluten sensitivity. Bua et al. from Italy report three patients aged 7, 17 and 19 years old, who were discovered to have eosinophilic esophagitis during evaluation for celiac disease. Biopsies of the lower esophagus obtained at the time of endoscopy performed to obtain duodenal biopsies to confirm celiac disease revealed eosinophilic esophagitis. All three had positive specific antibodies and small bowel biopsies diagnostic for celiac disease. However, they also had eosinophils greater than 20 per high power field found on esophageal biopsies though they were not symptomatic for eosinophilic esophagitis. I have also found eosinophilic esophagitis in patients with celiac disease and non-celiac gluten sensitivity. Like Bua, I believe there is a link to gluten and eosinophilic esophagitis. Two of the three patients in the Italian report failed to resolved their eosinophilic esophagitis on follow up biopsies. However,
Do you have symptoms or health issues that won’t go away and tests for food allergies and Celiac disease have been negative or inconclusive? Have you been told you have IBS, fibromyalgia, migraines, chronic fatigue or depression but feel that the medications and treatments recommended for you by doctors have not helped and you wonder if your symptoms might be related to your diet? Do you believe foods or chemicals in the foods you eat may be contributing to how poorly you feel and your unexplained symptoms yet doctors have told you that food allergy tests are negative or inconclusive? If you feel this way you are not alone. Now there may be help in a new form of food sensitivity testing to determine if your body is reacting negatively to the foods you are eating. The Food Doc is now partnering with Signet Diagnostic Corporation to bring this testing to patients on-line.If you are not sure you have symptoms from foods, take this food symptom survey on my secure website. High scores i
Zonulin levels are increased in celiac disease. However, chronic gluten (gliadin) exposure also affects zonulin in non-celiac intestine. The result is an increased gut permeability (or leaky gut). Just published in Gut is an article reporting abnormal claudin proteins result in patchy loss of barrier function or tight junctions (leaky gut) in active Crohn's disease. Drago et al published a report in the Scandinavian Journal of Gastroenterology in April 2006 that transient zonulin release could be triggered by exposure to gliadin even in normal intestine. An increase in intestinal permeability was noted in normal intestine though it was not as pronounced as in celiac disease patients. Intestinal tissue from celiac patients, even those in remission, exposed to gliadin demonstated a sustained increase in zonulin release resulting in significant and sustained increased intestinal permeability. Zonulin affects expression of the proteins claudin and occludin that constitute the cytoskele
Why celiac disease develops in 1% of people in the world who eat gluten-containing grains but not in the other 35-45% who are genetically at risk is not known. Having abnormal levels of gut bacteria levels is a risk. A 2005 study from Sweden revealed that altered short chain fatty acids (SCFA) levels produced by gut bacteria are a new piece to the puzzle. This also provides further support for the use of probiotics in the treatment and prevention of celiac disease. The healthy human gastrointestinal tract contains millions of live microbes that aid in digestion and produce various nutrients including SCFAs. These short fragments of fats when unbranched are health food for the intestine. Altered levels of SCFAs are measurable and result from an inbalance of gut microflora. Tjellström et al measured short chain fatty acids levels as an indicator of gut bacteria levels in children with celiac disease and healthy children and found significant differences. The found both untreated CD an
